ЭКСТРАКОРПОРАЛЬНОЕ ОЧИЩЕНИЕ КРОВИ ПРИ СЕПСИСЕ: СОВРЕМЕННОЕ СОСТОЯНИЕ ВОПРОСА




Р. Э. Якубцевич (Yakubtsevich R. E.)

Аннотация


В представленном обзоре литературы анализируются современные подходы к использованию методов экстракорпорального очищения крови в интенсивной терапии сепсиса. Анализу подвергнуты наиболее распространенные методики: гемосорбция, плазмаферез, продленная вено-венозная гемофильтрация и гемодиафильтрация, экстракорпоральная поддержка печени. Показано, что проведение экстракорпорального очищения крови при сепсисе, с позиции доказательной медицины – эффективное направление в лечении септических пациентов самого разного профиля и степени тяжести. Методиками с наибольшей доказательной базой в комплексном лечении пациентов с сепсисом стали продленные методы почечно-заместительной терапии, а также гемоперфузия через селективные гемосорбенты. Использование экстракорпорального очищения крови при сепсисе позволяет уменьшить летальность пациентов с самой разной степенью тяжести исходного состояния


Ключевые слова


сепсис; синдром полиорганной дисфункции; острые деструктивные панкреатиты; гемосорбция; плазмаферез; плазмафильтрация; продленные методы почечно-заместительной терапии; продленная вено-венозная гемофильтрация; продленная вено-венозная гемодиафильтра

Полный текст:

Литература


A new application for albumin dialysis in extracorporeal organ support: characterization of a putative interaction between human albumin and proinflmmatory cytokines IL-6 and TNFα / C. Pfensig [et al.] // Artif. Organs. – 2016. – Vol. 40 (4). – P. 397-402. – DOI: 10.1111/aor.12557.

A pilot study of selective lipopolysaccharide adsorption and coupled plasma fitration and adsorption in adult patients with severe sepsis / M. Yaroustovsky [et al.] // Blood Purif. – 2015. – Vol. 39 (1/3). – P. 210-217.

A randomised controlled trial of plasma fitration in severe paediatric sepsis / E. J. Long [et al.] // Crit. Care Resusc. – 2013. – Vol. 15 (3). – P. 198-204.

Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purifiation in experimental sepsis / Z. Y. Peng [et al.] // Kidney Int. ‒ 2012. ‒ Vol. 81 (4). ‒ P. 363- 369. – DOI: 10.1038/ki.2011.320.

Blood purifiation in sepsis: a new paradigm / Z. Peng [et al.] // Contrib. Nephrol. ‒ 2010. ‒ Vol. 165. ‒ P. 322-328. – DOI: 10.1159/000313773.

Charcoal haemoperfusion for phenytoin intoxication / P. P. Kumar [et al.] // Indian Pediatr. ‒ 2012. ‒ Vol. 49 (2). ‒ P. 152-153.

Charcoal haemoperfusion in amitriptyline poisoning: experience in 20 children / K. Bek [et al.] // Nephrology (Carlton). ‒ 2008. ‒ Vol. 13 (3). ‒ P. 193-197.

Clinical effects of direct hemoperfusion using a polymyxin-B immobilized column in solid organ transplanted patients with signs of severe sepsis and septic shock. A pilot study / F. Ruberto [et al.] // Int. J. Artif. Organs. ‒ 2007. ‒ Vol. 30 (10). ‒ P. 915-922.

Clinical effiacy of the biospecifi hemosorbent “Liposorb” / D. V. Vvedenskii [et al.] // Vestn. Ros. Akad. Med. Nauk. ‒ 2009. ‒ Vol. 10. ‒ P. 40-43.

Continuous versus intermittent renal replacement therapy: a Hetaanalysis / J. A. Kellum [et al.] // Intensive Care Med. ‒ 2002. ‒ Vol. 28 (1). ‒ P. 29-37.

Coupled plasma fitration adsorption combined with continuous veno-venous hemofitration treatment in patients with severe acute pancreatitis / C. He [et al.] // J. Clin. Gastroenterol. ‒ 2013. – Vol. 47 (1). ‒ P. 62-68.

Dai, S. R. Serum interleukin-17 as an early prognostic biomarker of severe acute pancreatitis receiving continuous blood purifiation / S. R. Dai, Z. Li, J. B. Zhang // Int. J. Artif. Organs. ‒ 2015. ‒ Vol. 38 (4). ‒ P. 192-198. – DOI: 0.5301/ijao.5000406.

David, S. Plasma exchange in treatment refractory septic shock: Presentation of a therapeutic add-on strategy / S. David, M. M. Hoeper, J. T. Kielstein // Med. Klin. Intensivmed. Notfmed. ‒ 2015. ‒ Vol. 112 (1). ‒ P. 134-138.

Detoxifying capacity and kinetics of prometheus – a new extracorporeal system for the treatment of liver failure / P. Evenepoel [et al.] // Blood Purif. ‒ 2005. ‒ Vol. 23 (5). ‒ P. 349-358.

Dynamics of elimination of bacterial endotoxins and cytokines from the blood of tumor patients with sepsis in hemoperfusion using carbon adsorbents / N. Y. Anisimova [et al.] // Bull. Exp. Biol. Med. ‒ 2011. ‒ Vol. 151, № 5. ‒ P. 622-624.

Early gut barrier dysfunction in patients with severe acute pancreatitis: attenuated by continuous blood purifiation treatment / J. Zhang [et al.] // Int. J. Artif. Organs. – 2010. – Vol. 33 (10). – P. 706-715.

Early veno-venous haemodiafitration for sepsis-related multiple organ failure / B. Page [et al.] // Crit. Care. ‒ 2005. ‒ Vol. 9. ‒ P. 755-763.

Effect of charcoal hemoperfusion for removal of plasma methotrexate in a patient with acute renal failure / T. Nemoto [et al.] // Pediatr. Hematol. Oncol. ‒ 2009. ‒ Vol. 26 (7). ‒ P. 520-525.

Effects of different doses in continuous veno-venous haemofitration on outcomes of acute renal failure: a prospective randomised trial / R. Ronco [et al.] // Lancet. ‒ 2000. ‒ Vol. 356. ‒ P. 26-30.

Effectivity of one session charcoal hemoperfusion treatment in severe carbamazepine poisoning / Y. Isik [et al.] // Iran. Red Crescent Med. J. ‒ 2013. ‒ Vol. 15 (8). ‒ P. 749-751. – DOI: 10.5812/ircmj.751.

Experience of use of endotoxin selective adsorption in patients with heavy severe sepsis after open-heart surgery / M. B. Yarustovsky [et al.] // Anesteziol. Reanimatol. ‒ 2014. – № 3. ‒ P. 39-46.

Extracorporeal blood therapy in sepsis and acute respiratory distress syndrome: the “purifying dream” / X. Xu [et al.] // Chin. Med. J. ‒ 2014. ‒ Vol. 127 (24). ‒ P. 4263-4270.

Extracorporeal treatment in phenytoin poisoning: systematic review and recommendations from the EXTRIP / K. Anseeuw [et al.] // Am. J. Kidney Dis. ‒ 2016. ‒ Vol. 67 (2). ‒ P. 187-197.

Faydhi, A. Use of plasmapheresis in acute pancreatitis secondary to hypertriglyceridemia / A. Faydhi, S. Mohidin, S. Al Eidarous // Universal J. Med. Sci. ‒ 2015. ‒ Vol. 3 (1). ‒ P. 28-32.

Haemodiafitration combined with resin-mediated adsorption as a therapy for hyperlipidemic acute pancreatitis / L. Mao-Qin [et al.] // Cell Biohem. Biophisics. ‒ 2014. ‒ Vol. 69 (3). ‒ P. 699-702.

Harm, S. Low-dose polymyxin: an option for therapy of Gramnegative sepsis / S. Harm, F. Gabor, J. Hartmann // Innate Immun. ‒ 2016. ‒ Vol. 22 (4). ‒ P. 274-283.

High-dose versus conventional-dose continuous veno-venous hemodiafitration and patient and kidney survival and cytokine removal in sepsis-associated acute kidney injury: a randomized controlled trial / J. T. Park [et al] // Am. J. Kidney Dis. ‒ 2016. ‒ Vol. 68 (4). ‒ P. 599-608.

Khoroshilov, S. E. Use of plasmapheresis in the enzymatic phase of severe acute pancreatitis / S. E. Khoroshilov, A. V. Nikulin, A. V. Marukhov // Gen. Reanimatol. ‒ 2013. ‒ Vol. 9, № 6. ‒ P. 57-60.

Kreisner, E. Charcoal haemoperfusion in the treatment of levothyroxine intoxication / E. Kreisner, M. Lutzky, J. L. Gross // Thyroid. ‒ 2010. ‒ Vol. 20 (2). – P. 209-212. – DOI: 10.1089/ thy.2009.0054.

Larsen, F. S. High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial / F. S. Larsen, L. E. Schmidt, C. Bernsmeier // J. Hepatol. ‒ 2016. ‒ Vol. 64, iss. 1. ‒ P. 69-78. – DOI: http://dx.doi.org/10.1016/j.jhep.2015.08.018.

Martin-Loeches, I. Management of severe sepsis: advances, challenges and current status / I. Martin-Loeches, M. M. Levy, A. Artigas // Drug Des. Devel. Ther. ‒ 2015. ‒ Vol. 9 (9). ‒ P. 2079-2088.

Modifiation of continuous veno-venous hemodiafitration with single-pass albumin dialysate allows for removal of serum bilirubin / L. S. Chawla [et al.] // Am. J. Kidney Dis. ‒ 2005. ‒ Vol. 45 (3). ‒ P. 51-56.

Panagiotou, A. Extracorporeal therapies in sepsis / A. Panagiotou, S. Gaiao, D. N. Cruz // J. Intensive Care Med. ‒ 2013. ‒ Vol. 28 (5). ‒ P. 281-295. ‒ DOI: 10.1177/0885066611425759.

PMX endotoxin removal in the clinical practice: results from the EUPHAS trial / M. Antonelli [et al.] // Contrib. Nephrol. – 2010. ‒ Vol. 167. ‒ P. 83-90. – DOI: 10.1159/000315922.

Polymixin B hemoperfusion in clinical practice: the picture from an unbound collaborative registry. The early use of Polymyxin B hemoperfusion in the abdominal sepsis 2 (EUPHAS 2) Collaborative Group / M. Antonelli [et al.] // Blood Purifi. – 2014. – Vol. 37, suppl. 1. – P. 22-25. – DOI: 10.1159/000356835.

Polymyxin B-immobilized fier hemoperfusion in patients with sepsis / T. Nakamura [et al.] // Dial. Transplant. ‒ 2003. ‒ Vol. 32, № 10. ‒ P. 602-607.

Rifai, K. Review article: clinical experience with prometheus / K. Rifai, M. P. Manns // Ther. Apher. Dial. ‒ 2006. ‒ Vol. 10 (2). ‒ P. 132-137. – DOI: 10.1111/j.1744-9987.2006.00354.x.

Rogiers, P. High-volume hemofitration in septic shock / P. Rogiers // Crit. Care. ‒ 2005. ‒ Vol. 9 (4). ‒ P. 329-330. – DOI: 10.1186/cc3734.

Santoro, A. Prometheus system: a technological support in liver failure / A. Santoro, S. Faenza, E. Mancini // Transplant. Proc. ‒ 2006. ‒ Vol. 38 (4). ‒ P. 1078-1082.

Sepsis-associated acute kidney injury / R. Alobaidi [et al.] // Semin. Nephrol. ‒ 2015. ‒ Vol. 35 (1). ‒ P. 2-11. – DOI: 10.1016/j. semnephrol.2015.01.002.

Shukla, A. M. Extracorporeal therapy in sepsis: are we there yet? / A. M. Shukla // Kidney Int. – 2012. ‒ Vol. 81 (4). ‒ P. 336-338. – DOI: 10.1038/ki.2011.375.

Shum, H. P. Extracorporeal blood purifiation for sepsis / H. P. Shum, W. W. Yan, T. M. Chan // Hong Kong Med. J. ‒ 2016. ‒ Vol. 22 (5). ‒ P. 478-485.

Sorbents in acute renal failure and end-stage renal disease: middle molecule and cytokine removal / J. F. Winchester [et al.] // Blood Purif. ‒ 2004. ‒ Vol. 22 (1). ‒ P. 73-77.

Stadlbauer, V. Effect of extracorporeal liver support by MARS and prometheus on serum cytokines in acute-on-chronic liver failure / V. Stadlbauer, P. Krisper, R. Aigner // Crit. Care. ‒ 2006. ‒ Vol. 19 (6). ‒ P. 169.

Subramanian, R. M. Extracorporeal liver support: a continuing challenge / R. M. Subramanian, J. A. Kellum // Crit. Care. ‒ 2007. ‒ Vol. 11 (1). ‒ P. 106.

The Euphrates trial (Evaluating the use of Polymyxin B hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock) : study protocol for a randomized controlled trial / D. J. Klein [et al.] // Trials. – 2014. – Vol. 15. ‒ P. 218. – DOI: 10.1186/1745-6215-15-218.

The Prometheus device for extracorporeal support of combined liver and renal failure / K. Rifai [et al.] // Blood Purif. ‒ 2005. ‒ Vol. 23 (4). ‒ P. 298-302.

Wang, H. L. Sequential blood purifiation therapy for critical patients with hyperlipidemic severe acute pancreatitis / H. L. Wang, K. J. Yu // World J. Gastroenterol. ‒ 2015. ‒ Vol. 28 (21). ‒ P. 6304-6309. – DOI: 10.3748/wjg.v21.i20.6304.

Elimination of inflmmatory mediators in sepsis by means of sorption detoxifiation methods / R. E. Yakubtsevich [et al.] // Anesteziol. Reanimatol. ‒ 2008. ‒ Vol. 6. ‒ P. 55-57.

Extracorporeal blood correction methods and thear impact on products of microbial metabolism in patients with sepsis / R. E. Yakubtsevich [et al.] // Anesteziol. Reanimatol. ‒ 2015. ‒ Vol. 5. ‒ P. 67-70.

Inflence of membrane plasmapheresis on the course of endotoxemia in acute destructive pancreatitis / B. S. Zaporozhchenko [et al.] // Klin. Khir. – 2013. – Vol. 9. – P. 26-28


Ссылки

  • На текущий момент ссылки отсутствуют.